Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
Introduced
Moved
Reached a final decision
Became law
Derived from the official record below.
Officially: “Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*” Read the full text
Official title shown verbatim from the official record. Plain-language summary coming as coverage deepens. Not legal advice.
2026-2027 session
Where it is
INT 1RA REF AHE · May 4, 2026
TRANS ASL · Jun 23, 2026
REP/ACS 2RA · Jun 23, 2026
PA · Jun 30, 2026
R/S SWR 2RS · Jun 30, 2026
SUB FOR · Jun 30, 2026
PS PBH · Jun 30, 2026
APP · Jul 8, 2026
The numbers
3
sponsors on the bill
Sponsors
Katz, AndreaSweeney, MarisaKearney, Vincent M.
Recorded votes
3RDG FINAL PASSAGESenate · 2026-06-30 · Y 38, N 2
3RDG FINAL PASSAGEGeneral Assembly · 2026-06-30 · Y 76, A 1, N 2
r/ACSGeneral Assembly · 2026-06-23 · Yes 7
Roll-call results shown verbatim from the New Jersey legislature’s records. A result reflects that roll call’s own motion, not the bill’s overall outcome.
Every fact on this page links to its source, starting with the official bill record. Last action: APP (Jul 8, 2026).